These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 31966753)
1. Two new Huang K; Chen Z; Zhang X Int J Clin Exp Pathol; 2017; 10(8):8863-8867. PubMed ID: 31966753 [TBL] [Abstract][Full Text] [Related]
2. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review. Miettinen M; Majidi M; Lasota J Eur J Cancer; 2002 Sep; 38 Suppl 5():S39-51. PubMed ID: 12528772 [TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases. Miettinen M; Sobin LH; Lasota J Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146 [TBL] [Abstract][Full Text] [Related]
4. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor. Zheng S; Chen LR; Wang HJ; Chen SZ Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649 [TBL] [Abstract][Full Text] [Related]
5. Mutations in exon 11 of the c-kit gene in a myogenic tumor and a neurogenic tumor as well as in gastrointestinal stromal tumors. Utility of c-kit mutation as a prognostic biomarker for gastrointestinal mesenchymal tumor. Yasuoka R; Sakakura C; Shimomura K; Fujita Y; Nakanishi M; Aragane H; Hagiwara A; Bamba M; Abe T; Yamagishi H Dig Surg; 2003; 20(3):183-91. PubMed ID: 12759497 [TBL] [Abstract][Full Text] [Related]
13. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours. Croom KF; Perry CM Drugs; 2003; 63(5):513-22; discussion 523-4. PubMed ID: 12600228 [TBL] [Abstract][Full Text] [Related]
14. [c-Kit and PDGFRA mutations and clinico-morphological features of gastrointestinal stromal tumors]. Beliakov IS; Anurova OA; Snigur PV; Tsyganova IV; Sel'chuk VIu; Mazurenko NN Vopr Onkol; 2007; 53(6):677-81. PubMed ID: 18416137 [TBL] [Abstract][Full Text] [Related]
15. KIT-negative gastrointestinal stromal tumor of the abdominal soft tissue: a clinicopathologic and genetic study of 10 cases. Yamamoto H; Kojima A; Nagata S; Tomita Y; Takahashi S; Oda Y Am J Surg Pathol; 2011 Sep; 35(9):1287-95. PubMed ID: 21836495 [TBL] [Abstract][Full Text] [Related]
16. The outcome of targeted therapy in advanced gastrointestinal stromal tumors (GIST) with non-exon 11 KIT mutations. Osuch C; Rutkowski P; Brzuszkiewicz K; Bylina E; Limon J; Siedlecki JA Pol Przegl Chir; 2014 Jul; 86(7):325-32. PubMed ID: 25222580 [TBL] [Abstract][Full Text] [Related]
17. The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST). Du CY; Shi YQ; Zhou Y; Fu H; Zhao G J Surg Oncol; 2008 Sep; 98(3):175-8. PubMed ID: 18618605 [TBL] [Abstract][Full Text] [Related]
18. [Status and clinical implication of c-kit and PDGFRA mutations in 165 cases of gastrointestinal stromal tumor (GIST)]. He HY; Fang WG; Zhong HH; Li Y; Zheng J; Du J; Heng WJ; Wu BQ Zhonghua Bing Li Xue Za Zhi; 2006 May; 35(5):262-6. PubMed ID: 16776995 [TBL] [Abstract][Full Text] [Related]
19. Familial gastrointestinal stromal tumors caused by the novel KIT exon 17 germline mutation N822Y. Thalheimer A; Schlemmer M; Bueter M; Merkelbach-Bruse S; Schildhaus HU; Buettner R; Hartung E; Thiede A; Meyer D; Fein M; Maroske J; Wardelmann E Am J Surg Pathol; 2008 Oct; 32(10):1560-5. PubMed ID: 18724244 [TBL] [Abstract][Full Text] [Related]
20. c-kit gene mutation at exon 17 or 13 is very rare in sporadic gastrointestinal stromal tumors. Kinoshita K; Isozaki K; Hirota S; Nishida T; Chen H; Nakahara M; Nagasawa Y; Ohashi A; Shinomura Y; Kitamura Y; Matsuzawa Y J Gastroenterol Hepatol; 2003 Feb; 18(2):147-51. PubMed ID: 12542597 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]